In the urinary tract, bladder cancer is the most common malignancy. It is a heterogenous
cancer type with approximately 30% presenting as muscle invasive bladder cancer with a …

Introduction The advancement of hybrid PET/CT or PET/MRI imaging for non-prostate
genitourinary cancers has not experienced the rapid progress of prostate cancer …

Background In contrast to other cancers, the concept of oligometastatic disease (OMD) has
not been investigated in bladder cancer (BC). Objective To develop an acceptable definition …

Objective To assess real‐world oncological outcomes between the radical cystectomy (RC)
group and non‐RC group for early relapse and refractory disease. Methods We …

Purpose Pronounced underuse of radiotherapy (RT) in muscle-invasive bladder cancer
(MIBC) is reported. This study aims to assess the awareness about the role of RT in different …

In patients with metastatic deposits amenable to surgical resection, metastasectomy stands
as a promising avenue. Metastatic-directed radiotherapy has demonstrated local control and …

Purpose To review available and emerging evidence of radiotherapy for symptom
management and disease control in metastatic bladder cancer. Methods A literature search …

Background: The role of molecular imaging in urothelial cancer is less defined than other
cancers, and its utility remains controversial due to limitations such as high urinary tracer …

Molecular imaging with positron emission tomography is a powerful tool in bladder cancer
management. In this review, we aim to address the current place of the PET imaging in …

To analyze the application value of computed tomography (CT) based on a three‐
dimensional reconstruction algorithm in perioperative nursing research and prognosis …